Claudia Biguetti
Biographic Data
| ID | 8524654 |
|---|---|
| NAME | Claudia Biguetti |
| GIVEN NAMES | Claudia |
| FAMILY NAME | Biguetti |
| SIGNATURE | BIGUETTI C |
| AFFILIATIONS | The University of Texas at Arlington |
| ORCID | 0000-0003-4503-3108 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for Sars-CoV-2 (covid-19)
Chloroquine (CQ) and its analog hydroxychloroquine (HCQ) were recently included in several clinical trials as potential prophylactic and therapeutic options for SARS-CoV-2 infection/covid-19. However, drug effectiveness in preventing, treating, or slowing the progression of the disease is still unknown. Despite some initial promising in vitro results, rigorous pre-clinical animal studies and randomized clinical trials have not been performed yet.…
No prominent works on this page.
Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for Sars-CoV-2 (covid-19)
Chloroquine (CQ) and its analog hydroxychloroquine (HCQ) were recently included in several clinical trials as potential prophylactic and therapeutic options for SARS-CoV-2 infection/covid-19. However, drug effectiveness in preventing, treating, or slowing the progression of the disease is still unknown. Despite some initial promising in vitro results, rigorous pre-clinical animal studies and randomized clinical trials have not been performed yet.…
Chloroquine (1 works) · Clinical trial (1 works) · Coronavirus disease 2019 (COVID-19) (1 works) · COVID-19 Clinical Research Studies (1 works) · Disease (1 works) · Drug (1 works) · Drug-Induced Ocular Toxicity (1 works) · Hydroxychloroquine (1 works) · Immunology (1 works) · Immunology (1 works)